Atlas Trials

An Alternative Dose Interval Study in Participants With Hidradenitis Suppurativa Receiving Brodalumab

Clinical trial NCT04249713 · WITHDRAWN

Trial details

NCT number
NCT04249713
Sponsor
Rockefeller University
Status
WITHDRAWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Hidradenitis Suppurativa
Start date
2020-02-03
Primary completion
2020-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.